Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Supranuclear Palsy, Progressive 1Spinal Cord Injuries 1Prostatic Neoplasms 1Parkinson Disease 1Myasthenia Gravis 1Multiple System Atrophy 1Lewy Body Disease 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Essential Tremor 1Carcinoma, Renal Cell 1Alzheimer Disease 1

Interventions

Radiosurgery 113Temozolomide 104Bevacizumab 70Radiotherapy 66Magnetic Resonance Spectroscopy 66Carboplatin 29pembrolizumab 27Irinotecan 26Surgical Procedures, Operative 25Nivolumab 23Radiation 22Etoposide 22Magnetic Resonance Imaging 21Ipilimumab 21Erlotinib Hydrochloride 21Cyclophosphamide 21Surveys and Questionnaires 19Aminolevulinic Acid 18Specimen Handling 16Pemetrexed 16Mental Status and Dementia Tests 16Cisplatin 16Carmustine 15Topotecan 14Trastuzumab 13Saline Solution 12Neuropsychological Tests 12Gefitinib 11Filgrastim 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Brain Neoplasms × Neurofeedback × Clear all
NCT07085494 2026-01-27

Neurofeedback and Cognitive Training for PBTS

The University of Hong Kong

Phase NA Enrolling by invitation
50 enrolled
CNS

Brain Neoplasms

NCT00961922 2012-10-04

PRISMA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Unknown
105 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡